The ADAR1 expression was upregulated in patients with liver metastases related to concurrent liver metastases (cytoplasm: p < 0.001), RAS mutant-type CRC (nucleus: p < 0.05), and remnant liver recurrence after hepatic metastasectomy (cytoplasm: p < 0.05; Fig. 3b–e). This evidence concerns the gene ADAR and colorectal carcinoma.